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Abstract: This work was intended to develop self-assembly lipids for incorporating G-protein
coupled receptors (GPCRs) in order to improve the success rate for nuclear magnetic resonance
spectroscopy (NMR) structural elucidation. We hereby report the expression and purification of
uniformly 15 N-labeled human cannabinoid receptor-2 domain in insect cell media. The domain was
refolded by screening several membrane mimetic environments. Different q ratios of isotropic bicelles
were screened for solubilizing transmembrane helix 6, 7 and 8 (TMH67H8). As the concentration of
dimyristoylphosphocholine (DMPC) was increased such that the q ratio was between 0.16 and 0.42,
there was less crowding in the cross peaks with increasing q ratio. In bicelles of q = 0.42, the maximum
number of cross peaks were obtained and the cross peaks were uniformly dispersed. The receptor
domain in bicelles beyond q = 0.42 resulted in peak crowding. These studies demonstrate that GPCRs
folding especially in bicelles is protein-specific and requires the right mix of the longer chain and
shorter chain lipids to provide the right environment for proper folding. These findings will allow
further development of novel membrane mimetics to provide greater diversity of lipid mixtures than
those currently being employed for GPCR stability and folding, which are critical for both X-ray and
NMR studies of GPCRs.
Keywords: selective and uniformly labeling; insect cells; bicelles; NMR

1. Introduction
The G-protein coupled receptor (GPCR) superfamily constitutes a large and diverse family
of proteins in eukaryotic membranes and are targets of most drugs [1–3]. They comprise
a bundle of seven transmembrane α helices connected by intracellular and extracellular loops [4].
Tremendous challenges in their expression and purification, coupled with optimization of appropriate
membrane-mimetic systems for reconstituting GPCRs, have isolated the GPCR family as the largest
subset of transmembrane proteins yet to be fully characterized by biophysical techniques [5]. This has
hampered interpretation of biochemical findings, and thus limits the development of rational drug
discovery among therapeutically important GPCRs. Among the structural biology techniques
applied to GPCR characterization, X-ray crystallography has enjoyed much success in providing
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high-resolution structures of isolated GPCRs in complex with selected ligands reconstituted in
detergent micelles [6,7]. The first crystal structure to be determined was that of rhodopsin, which was
stabilized by a covalently bound ligand that held the receptor in an inactive state [7]. Efforts to explain
the complex behavior of GPCRs and their ability to recognize a wide range of ligands led to other
crystal structures of engineered receptors, among which are the human β2 -adrenergic receptor (hβ2 AR),
turkey β1 AR, as well as human D3 dopamine receptors (hD3Rs), also in detergent micelles [8–10].
Thus, the structural characterization of GPCRs and understanding their mechanisms of action have
recently been elevated in importance as a means to improve the success of drug discovery [1,11].
The major issues in studying GPCRs with NMR are the challenges in controlling the
conformational plasticity and thermal stability (Tm ) of the receptor in detergent micelles to
ensure the system is within the limits of NMR experiments [5,12,13]. The most widely used
environments to produce properly folded membrane proteins for NMR studies are through the
reconstitution in membrane-mimetic environments, such as organic solvents [14–16] and detergent
micelles [17–19]. Another technique to study membrane proteins in lipid bilayers involves the
utilization of a combination of a short-chain detergent, such as dihexanoylphosphocholine (DHPC),
and a longer chain lipid, such as dimyristoylphosphocholine (DMPC), at the appropriate concentrations
to yield discoidal membranes called “bicelles” [18,20–24].
Recently, monodispersed nanodisc environments have also been adopted to stabilize the
seven-transmembrane (7-TM) bundle to maintain the conformational dynamics and functionality
of chemokine receptor type 5 (CXCR5) and hβ2 AR receptors [5,25]. Structural studies of pSRII,
a homolog protein of GPCRs, also suggest that choosing the best membrane mimetic is key to the
preparation of homogenous sample for obtaining a good NMR spectrum [26]. Organic solvents such
as trifluoroethanol (TFE) and 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) have also been applied to study
fragments of GPCRs using NMR techniques [14,27–29]. All these results further support that NMR is
a very important tool in the structural determination of membrane proteins for drug discovery, as long
as the right microenvironment is identified.
The human cannabinoid receptor 2 (hCB2), a member of the class A type GPCR, is a potential
drug target and yet, to date, direct structural information regarding its function is very limited [5,7,30].
As in other GPCRs, hCB2 is defined by iconic seven-transmembrane helix (7-TMH) bundle connected
by intracellular and extracellular loops, with TMH1–5 comprising one domain and TMH6,7 another
domain [31]. From occluded surface area calculations, most ligands targeting type A GPCRs make
contact with TMH6,7, with sporadic selection of domains from TMH1–5 [32]. Other ligands target
extracellular portions of TMH1–5, where the reorientation of the positions of these helices in detergent
micelles appears to redefine the location of the ligand-binding pocket. The inability to define accurately
the ligand-binding site is due to GPCRs’ conformational plasticity arising from enhanced dynamics
within detergent micelles [33–35]. Therefore, the membrane environment has a significant role to
play in the activity of GPCRs such as the hCB2 receptor. In this current work, efforts were devoted
to screening a library of membrane-mimetic environments for solubilizing hCB2 TMH67H8 receptor
domain for the purpose of structural studies. First, through modifications to commercially available
insect cell growth media, selectively 15 N-labeled TMH67H8 was produced in which all the leucine
(Leu) residues were replaced by their isotopic variants to screen various membrane mimetics for the
NMR studies. Then, the same variant was expressed with our modified insect cell media to produce
15 N and 13 C double-labeled TMH67H8 for further analysis of the conformation of the receptor domain
in the best membrane environment.
TMH67H8 virus of hCB2 was amplified using the titerless infected-cells preservation and scale-up
method for producing milligram quantities of the receptor domain [36]. The incorporation of
the hCB2 receptor domain into selected detergent micelles and isotropic bicelles were conducted
utilizing a modified approach. NMR experiments were then conducted utilizing 1 H-15 N transverse
relaxation-optimized spectroscopy (TROSY) pulse sequence on both selectively and uniformly labeled
hCB2 receptor domains to determine the best conditions for folding and the implication of the lipid
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environment on the conformation of TMH67H8. Among the membrane mimetics screened, the bicelle
environment provided remarkable variations in the 1 H-15 N TROSY spectra through changes in the
DMPC/DHPC lipid ratio, indicative of a properly folded TMH67H8.
2. Experimental Procedures
2.1. Materials
n-Dodecyl-β-D-maltopyranoside (DDM) was purchased from Affymetrix (Santa Clara, CA, USA).
n-Dodecylphosphocholine (DPC), TFE, and HFIP were obtained from Cambridge Isotopes (Andover,
MA, USA), and all lipids were obtained from Avanti Polar Lipids (Alabaster, AL, USA).
2.2. hCB2 TMH67H6 Expression and Purification
Recombinant DNA Construction: The nucleotides corresponding to the human cannabinoid
receptor-2 TMH6,7H8 was designed such that there was a BamHI and Ncol sites at the N-terminus and
EcoRI at the C-terminus. The N-terminus was flag-tagged, whereas the six histidines were attached
at the C-terminus to facilitate purification using affinity chromatography. The flag-tag was used to
measure the level of expression. The modified gene was then engineered into the expression vector.
Expression: Spodoptera frugiperda (Sf9) cells were grown in a small volume of pre-warmed ES 921
media (Expression Systems, St. Davis, CA, USA). Once the cell density reached 2 × 106 cells/mL,
the cells were diluted with pre-warmed ES 921 leucine-depleted media (Expression Systems) to a cell
density of 0.6 × 106 cells/mL. The cells were infected with baculovirus at a dilution of 1:2000 when
they had reached a cell density of 1 × 106 cells/mL. At about 15 h and 48 h post infection, 150 mg/L
and 300 mg/L of 15 N/13 C amino acids (Cambridge Isotope Laboratories, Inc., Cambridge, MA, USA)
were respectively added to the cells. Once the cells’ diameter had increased 3–4 µm and the cell
viability was just below 95%, the cells were centrifuged at 5000× g for 10 min at 4 ◦ C. The supernatant
was removed and the cell pellets stored at −80 ◦ C. For the Western blot, cell samples of 1 mL were
collected every 24 h after infection. The samples were centrifuged at 13,700× g for 3 min and stored at
−20 ◦ C.
Purification: The frozen cell pellets of the insect cell membranes were dissolved in a buffer
containing 50 mM phosphate, 200 mM NaCl, 8 M urea, and 1% DM at pH = 7.4. Extensive vortexing
was performed at room temperature and the supernatant was isolated by centrifugation at 4500 rpm
for 30 min. The supernatant was incubated with nickel NTA resin (Qiagen, Germantown, MD, USA)
for at least 12 h at room temperature. After 12 h, the resin was washed with five column volumes of
50 mM phosphate, 200 mM NaCl, 8 M urea, 1% DM, and 5 mM imidazole at pH = 7.4. After washing,
TMH67H8 was eluted from the resin with 50 mM phosphate, 200 mM NaCl, 0.1% DM, and 200 mM
imidazole at pH = 7.4. The protein was precipitated from solution by extensive dialysis against 50 mM
phosphate pH = 7.4. The precipitated protein was washed several times with 50 mM phosphate buffer
and lyophilized in 60% 1,1,1,3,3,3-hexafluoro-2-propanol.
2.3. Reconstitution of TMH67H8 and NMR Experiments
The organic solvent samples were prepared by directly dissolving the lyophilized samples in
the appropriate organic solvent:water (30% TFE or HFIP) mixture. The reconstitution of TMH67H8
into bicelles was performed by slowly diluting the protein solution in 100 mM DDM into a 10-fold
excess of 15% total lipids (DMPC/DHPC, molar ratio = 0.25) (Avanti Polar Lipids, Alabaster, AL, USA)
containing 10 mM phosphate and 20 mM KCl, pH = 6.7, at room temperature [13]. The TMH67H8 in
the bicelles solution was then centrifuged in a 30 kDa cutoff membrane to a volume of about 400 µL
and total protein-to-lipid ratio of 1:50. The detergent micelle samples were prepared by dissolving
the appropriate amount of lyophilized TMH67H8 in 100 mM DDM or 100 mM DPC in 10 mM
phosphate and 20 mM KCl, pH = 6.7, to give final protein-to-lipid molar ratio of 1:50. All NMR spectra
were recorded at 318 K on an Agilent (Varian, Palo Alto, CA, USA) 600 MHz VNMRS spectrometer
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equipped with a triple-resonance probehead. DSS (4,4-dimethyl-4-silapentane-1-sulfonic acid) was
used as chemical shift reference. Two-dimensional 1 H-15 N-TROSY spectra were recorded with ranges
from 320 to 448 transients per increment, acquisition times of 41 ms (t1 , 15 N) and 106 ms (t2 , 1 H),
and a time domain data size of 80(t1 ) × 1024(t2 ) complex points.
2.4. Circular Dichroism Experiments
Small micelles composed of either 1,2-dihexanoyl-sn-glycero-3-phosphocholine (D-6-PC,) or
DPC were prepared in 10 mM Tris buffer, pH ~7.5, containing 0.5 mM EDTA and 10 Mm NaCl.
The hCB2 TMH67H8 peptide was dissolved in 30% TFE/H2 O or incorporated into micelles at a 100:1
lipid-to-peptide molar ratio. Analysis of peptide secondary structure was then performed with
a nitrogen-flushed J-810 spectropolarimeter (Jasco Inc., Easton, MD, USA) controlled by Spectra
Manager (version 1.15.00, Jasco Instruments, Easton, MD, USA). Spectra were recorded from 280
to 185 nm at 23 ◦ C using a 1 cm cuvette, a scan rate of 1 nm/min, and an average of three scans
per sample.
2.5. Molecular Dynamics of TMH67H8
Twelve-hundred-picosecond simulations of TMH67H8 were undertaken here using the Desmond
molecular dynamics software package with an OPLS-AA 2005 force field including data for the
POPC (Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) bilayer, along with the simple point charge
(SPC) model for water. Force field parameters for TMH67H8 were constructed by utilizing existing
parameters for similar atom types. In the simulation setup, M-SHAKE constraints were used on all
covalent bonds involving hydrogen atoms to allow an iteration time step of 2 fs. The reference system
propagator algorithm (RESPA) was used to integrate the equations of motion using periodic boundary
conditions on this orthorhombic simulation system (35 Å × 30 Å × 20 Å). The initial confirmations for
TMH67H8 in the POPC bilayer were constructed by placing the minimized solute into pre-equilibrated
POPC bilayer (approximate 80 POPC each layer, and 13,240 waters) according to the hypothesis therein.
The simulation was stable after 1200 ps.
3. Results
3.1. Membrane-Mimetic Chemical Structures
The structures of TFE and HFIP are displayed in Figure 1A,B. These alcohols are often used to
induce alpha-helical properties on proteins, although the mechanism through which they promote
alpha-helical properties is unknown. The structure of the DDM detergent revealed dual hydrophobic
(the lipid tail) and hydrophilic (maltose) properties that facilitate lipid displacement and provide
a lipid-like environment for membrane proteins (Figure 1C). DPC is a synthetic phosphodiester
detergent with the phosphoric acid having ester bonds between choline, (CH3 )3 N(CH2 )2 OH,
and dodecyl alcohol, CH3 (CH)11 OH (Figure 2A). Unlike DPC, DHPC and DMPC have two acyl chains,
hexanoyl alcohol, (CH3 (CH2 )5 OH, and myristoyl alcohol, (CH3 (CH2 )13 OH, respectively bonded to
a glycerol backbone, and both having phosphodiester bond with the phosphoric acid linking to
a choline (CH3 )3 N(CH2 )2 OH group (Figure 2B,C).
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3.3. NMR Analysis of TMH67H8 as a Function of Bicelle q Ratio
While the size of the TFE, HFIP, and DPC cannot be varied upon changes in concentration,
While
the size
size can
of the
TFE, HFIP,by
and
DPC cannot
be varied upon
changes
concentration,
isotropic
bicelle
be influenced
adjusting
the concentrations
of the
longerinchain
DMPC lipids.
31
isotropic
bicelle
size
can
be
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by
adjusting
the
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of
the
longer
chain
DMPC
As shown in Figure 6A, P NMR was used to estimate the DMPC/DHPC ratio by titrating
DMPC
31P NMR was used to estimate the DMPC/DHPC ratio by titrating
lipids.
As
shown
in
Figure
6A,
1
15
into the bicelles to obtain q ratios of 0.16, 0.25, and 0.42. The corresponding H- N TROSY-HSQC
DMPC into the bicelles to obtain q ratios of 15
0.25, and 0.42. The corresponding 1H-15N TROSYexperiments
were conducted on uniformly 0.16,
N-labeled
TMH67H8 in all three molar q ratios and the
HSQC experiments were conducted on uniformly 15N-labeled TMH67H8 in all three molar q ratios
folding of the receptor domain investigated (Figure 6B). It is evident that by increasing the concentration
and the folding of the receptor domain investigated (Figure 6B). It is evident that by increasing the
of DMPC in the bicelle system, the number of cross peaks and the extent of dispersion of the resonances
concentration of DMPC in the bicelle system, the number of cross peaks and the extent of dispersion
in the 1 H-15 N TROSY spectra
improve (from q = 0.16 to q = 0.42). It was also observed that protein
of the resonances in the 1H-15N TROSY spectra improve (from q = 0.16 to q = 0.42). It was also observed
precipitation during the NMR experiments decreases as we move from low DMPC concentration
that protein precipitation during the NMR experiments decreases as we move from low DMPC
(qconcentration
= 0.16) to high
= 0.42).
This
demonstrates
that the size
ofthe
thesize
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(q =(q0.16)
to high
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= 0.42). This observation
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that
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receptor domain.
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3.4. Modeling TMH67H8 in a Membrane-Mimetic Environment
3.4. Modeling TMH67H8 in a Membrane-Mimetic Environment
TMH67H8 was modeled in a POPC environment to investigate the interaction and orientation
TMH67H8 was modeled in a POPC environment to investigate the interaction and orientation
of the receptor fragment. Figure 7A shows the structure of TMH67H8 after 900 ps of simulation.
ofClearly,
the receptor
Figure
7Aare
shows
the
of TMH67H8
after loop
900 3ps(EC3)
of simulation.
Leu269,fragment.
Leu273, and
Leu287
located
in structure
the unstructured
extracellular
region
Clearly,
Leu269,
Leu273,
and
Leu287
are
located
in
the
unstructured
extracellular
loop
3
(EC3)
of TMH67H8, whereas L314 is located in the intracellular helix 8 portion of the full receptor.region
The of
TMH67H8,
whereas
L314
is
located
in
the
intracellular
helix
8
portion
of
the
full
receptor.
The
cartoon
cartoon conforms to the NMR structure of TMH67H8 that has already been published by Tiburu et
conforms
to the
NMR structureroot-mean-square-deviation
of TMH67H8 that has already
been
published
by Tiburu
et al.
al. [21]. The
energy-minimized
(RMSD)
profile
is displayed
in Figure
7B[21].
The
energy-minimized
root-mean-square-deviation (RMSD) profile is displayed in Figure 7B after
after
1200 ps of simulation.
1200 ps of simulation.
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4. Discussion
4. Discussion
TFE and HFIP media have been used in the past to determine the structure of similar
TFE and HFIP media have been used in the past to determine the structure of similar
transmembrane proteins and receptor fragments because of their ability to stabilize their alphatransmembrane proteins and receptor fragments because of their ability to stabilize their alpha-helical
helical structure [14,28,39–41]. The secondary structures stabilized by either TFE and HFIP were often
structure [14,28,39–41]. The secondary structures stabilized by either TFE and HFIP were often
assumed to reflect conformations that prevail in the early stages of protein folding [42,43]. We
assumed to reflect conformations that prevail in the early stages of protein folding [42,43]. We therefore
therefore tested the ability of these organic solvents to solubilize and stabilize TMH67H8
tested the ability of these organic solvents to solubilize and stabilize TMH67H8 conformation for
conformation for NMR studies. The most noticeable difference between the TFE and HFIP NMR
NMR studies. The most noticeable difference between the TFE and HFIP NMR spectra was that fewer
spectra was that fewer cross peaks were identified in the former, suggesting TFE is the least helixcross peaks were identified in the former, suggesting TFE is the least helix-inducing organic solvent
inducing organic solvent for TMH67H8 conformation. HFIP, an alcohol with six fluorine atoms, had
for TMH67H8 conformation. HFIP, an alcohol with six fluorine atoms, had demonstrated to be the
demonstrated to be the most effective membrane-mimetic environment. It was believed that the
most effective membrane-mimetic environment. It was believed that the presence of two CF3 groups
presence of two CF3 groups made HFIP a better H-bond donor, resulting in a more compact
made HFIP a better H-bond donor, resulting in a more compact TMH67H8 structure as observed in
TMH67H8 structure as observed in other NMR studies of membrane proteins in HFIP [28]. To further
other NMR studies of membrane proteins in HFIP [28]. To further validate the suitability of using
validate the suitability of using HFIP for structural characterization of the receptor domain, we
HFIP for structural characterization of the receptor domain, we performed similar experiments with
performed similar experiments with uniformly 15N-labeled TMH67H8. The 15N HSQC spectrum
uniformly 15 N-labeled TMH67H8. The 15 N HSQC spectrum produced in HFIP was broad with very
produced in HFIP was broad with very few resolved peaks (data not shown). The results indicated
few resolved peaks (data not shown). The results indicated that the spread of the HSQC resonance
that the spread of the HSQC resonance peaks in HFIP did not reflect a properly folded TMH67H8
peaks in HFIP did not reflect a properly folded TMH67H8 and, thus, the receptor conformational
and, thus, the receptor conformational integrity was not maintained, even though the selectively
integrity was not maintained, even though the selectively labeled receptor showed promise in its
labeled receptor showed promise in its utilization for structural studies.
utilization for structural studies.
Most detergent micelles, including DPC, have also been utilized in solubilizing membrane
Most detergent micelles, including DPC, have also been utilized in solubilizing membrane
proteins for both X-ray and solution NMR studies [10,44]. DPC in particular contains spatially distinct
proteins for both X-ray and solution NMR studies [10,44]. DPC in particular contains spatially distinct
hydrophobic and hydrophilic regions that can influence the structural integrity of TMH67H8 and can
hydrophobic and hydrophilic regions that can influence the structural integrity of TMH67H8 and can
affect the overall shape and distribution of the HSQC resonance peaks. Thus, DPC might be another
affect the overall shape and distribution of the HSQC resonance peaks. Thus, DPC might be another
important solubilizing agent for TMH67H8 due to its ability to better protect the TM region of the
important solubilizing agent for TMH67H8 due to its ability to better protect the TM region of the
receptor domain as a result of protein–lipid interactions that match the hydrophobic length of DPC
receptor domain as a result of protein–lipid interactions that match the hydrophobic length
of DPC to
to the alpha-helical regions of TMH67H8. The cross peaks in the DPC spectrum of 15N selectively
the alpha-helical regions of TMH67H8. The cross peaks in the DPC spectrum of 15 N selectively labeled
labeled TMH67H8 were sharp and more dispersed compared to the HFIP spectrum. Again, we tested
TMH67H8 were sharp and more dispersed compared to the HFIP spectrum. Again, we tested the
the feasibility of using DPC for structural determination of uniformly labeled TMH67H8, but as in
feasibility of using DPC for structural determination of uniformly labeled TMH67H8, but as in HFIP,
HFIP, DPC failed to produce well-dispersed cross peaks (data not shown). When different
DPC failed to produce well-dispersed cross peaks (data not shown). When different concentrations of
concentrations of DPC were used to reconstitute the receptor domain, more heterogeneous and
DPC were used to reconstitute the receptor domain, more heterogeneous and disproportionally varied
disproportionally varied resonance peaks were produced that indicated there were secondary
structural fluctuations within TMH67H8 in the DPC environment regardless of the concentration of
the detergent micelle.

Membranes 2017, 7, 10

10 of 13

resonance peaks were produced that indicated there were secondary structural fluctuations within
TMH67H8 in the DPC environment regardless of the concentration of the detergent micelle.
Our next option was to reconstitute the receptor domain bicelles comprising a mixture of DMPC
and DHPC. The complex was investigated using 1 H-15 N TROSY-HSQC resonances to observe the
extent of folding of TMH67H8. There was clear evidence that DMPC/DHPC q = 0.25–0.42 provided
well distinct resonance peaks suggesting the existence of a critical window of DMPC/DHPC q ratio
can support the conformation of membrane proteins for structural determination. This q ratio window
seemed to be transmembrane (TM) protein dependent and one TM protein that prefers a particular
q ratio may not necessarily apply to another TM protein. These findings will allow further development
of novel membrane mimetics to provide greater diversity of lipid mixtures than those currently being
employed for GPCR stability and folding, which is critical for both X-ray and NMR studies of GPCRs.
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DHPC
DMPC
DDM
DPC
DSS
GPCRs
hCB2
HSQC
Leu
MALDI-TOF
TFE
HFIP
RMSD
Sf9
TMH
TROSY

Dihexanoylphosphocholine
Dimyristoylphosphocholine
n-Dodecyl-β-D-Maltopyranoside
n-Dodecylphosphocholine
4,4-dimethyl-4-silapentane-1-sulfonic acid
G-protein coupled receptors
human cannabinoid receptor 2
heteronuclear single quantum coherence or correlation
Leucine
Matrix-assisted laser desorption ionization time-of-flight
Trifluoroethanol
1,1,1,3,3,3-hexafluoro-2-propanol
Root-mean-square-deviation
Spodoptera frugiperda
Transmembrane helix
Transverse relaxation-optimized spectroscopy
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